Godefrooij D - Search Results

1

Optimal management of pediatric keratoconus: challenges and solutions.

Olivo-Payne A, Abdala-Figuerola A, Hernandez-Bogantes E, Pedro-Aguilar L, Chan E, Godefrooij D. Olivo-Payne A, et al. Among authors: godefrooij d. Clin Ophthalmol. 2019 Jul 10;13:1183-1191. doi: 10.2147/OPTH.S183347. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31371915 Free PMC article.

2

Cost-Effectiveness Analysis of Corneal Collagen Crosslinking for Progressive Keratoconus.

Godefrooij DA, Mangen MJ, Chan E, O'Brart DPS, Imhof SM, de Wit GA, Wisse RPL. Godefrooij DA, et al. Ophthalmology. 2017 Oct;124(10):1485-1495. doi: 10.1016/j.ophtha.2017.04.011. Epub 2017 May 19. Ophthalmology. 2017. PMID: 28532974

3

Higher order optical aberrations and visual acuity in a randomized controlled trial comparing transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus.

Godefrooij DA, Kandoussi ME, Soeters N, Wisse RP. Godefrooij DA, et al. Clin Ophthalmol. 2017 Oct 30;11:1931-1936. doi: 10.2147/OPTH.S139358. eCollection 2017. Clin Ophthalmol. 2017. PMID: 29133974 Free PMC article.

4

Clinical Evaluation and Validation of the Dutch Crosslinking for Keratoconus Score.

Wisse RPL, Simons RWP, van der Vossen MJB, Muijzer MB, Soeters N, Nuijts RMMA, Godefrooij DA. Wisse RPL, et al. JAMA Ophthalmol. 2019 Jun 1;137(6):610-616. doi: 10.1001/jamaophthalmol.2019.0415. JAMA Ophthalmol. 2019. PMID: 30920597 Free PMC article.

5

Corneal Cross-Linking for Pediatric Keratoconus: Long-Term Results.

Godefrooij DA, Soeters N, Imhof SM, Wisse RP. Godefrooij DA, et al. Cornea. 2016 Jul;35(7):954-8. doi: 10.1097/ICO.0000000000000819. Cornea. 2016. PMID: 27027921

6

Using Machine Learning to Monitor Keratoconus Progression-Reply.

Wisse RPL, Godefrooij DA, Nuijts RMMA. Wisse RPL, et al. Among authors: godefrooij da. JAMA Ophthalmol. 2019 Dec 1;137(12):1468. doi: 10.1001/jamaophthalmol.2019.4201. JAMA Ophthalmol. 2019. PMID: 31670783 No abstract available.

7

The Independent Effect of Various Cross-Linking Treatment Modalities on Treatment Effectiveness in Keratoconus.

Godefrooij DA, Roohé SL, Soeters N, Wisse RPL. Godefrooij DA, et al. Cornea. 2020 Jan;39(1):63-70. doi: 10.1097/ICO.0000000000002168. Cornea. 2020. PMID: 31577628

8

Nationwide epidemiological approach to identify associations between keratoconus and immune-mediated diseases.

Claessens JLJ, Godefrooij DA, Vink G, Frank LE, Wisse RPL. Claessens JLJ, et al. Among authors: godefrooij da. Br J Ophthalmol. 2022 Oct;106(10):1350-1354. doi: 10.1136/bjophthalmol-2021-318804. Epub 2021 Apr 20. Br J Ophthalmol. 2022. PMID: 33879468 Free PMC article.

9

Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study.

Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP. Godefrooij DA, et al. Am J Ophthalmol. 2017 Mar;175:169-172. doi: 10.1016/j.ajo.2016.12.015. Epub 2016 Dec 28. Am J Ophthalmol. 2017. PMID: 28039037

10

Predictors for treatment outcomes after corneal crosslinking for keratoconus: a validation study.

Godefrooij DA, Boom K, Soeters N, Imhof SM, Wisse RP. Godefrooij DA, et al. Int Ophthalmol. 2017 Apr;37(2):341-348. doi: 10.1007/s10792-016-0262-z. Epub 2016 May 24. Int Ophthalmol. 2017. PMID: 27221267 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page